A more robust TH1 immune response, and subsequent myeloid cell activation in COVID-19 could explain this peculiar cytokine signature, in which VCAM1 could be the consequence, but also a protagonist of the auto-inflammatory loop mediating endothelial and lung immune cell infiltration and tissue damage. The gene discussed is VCAM1; the disease is COVID-19.